JOURNAL OF CLINICAL SURGERY ›› 2024, Vol. 32 ›› Issue (7): 693-696.doi: 10.3969/j.issn.1005-6483.2024.07.007

Previous Articles     Next Articles

Programmed cell death 10 mediates the migration of glioma cells by regulating the PP2A/p38 signaling pathway

WAN Xueyan,XIE Jiazhao,ZHAO Kai,KONG Fanli,MEI Qi   

  1. Department of Neurosurgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
  • Received:2024-03-27 Online:2024-07-20 Published:2024-07-20

PDF (PC)

6

PDF (Mobile)

2

Abstract: Objective To explore the molecular mechanism of programmed cell death 10 (PDCD10) mediating glioma migration.Methods A PDCD10-silenced glioma cell line (U251) was constructed by siRNA,and the cells were treated with Okadaic Acid (OA),a protein phosphatase 2A (PP2A) phosphatase inhibitor,to investigate the effect of down-regulation of PDCD10 on the behavior of U251 cells; Western Blot (WB) was applied to detect the expression of PDCD10,PP2A,PP2Ac-307,p38 and pP38 in the control group and PDCD10 down-regulation group of U251 cells,to study the mechanism of PDCD10 regulation of PP2A/p38 signaling.Results Down-regulation of PDCD10 in U251 cells promoted the cells migration (P<0.05),which could be inhibited by PP2A phosphatase inhibitor OA (P<0.01).Further studies showed that down-regulation of PDCD10 promoted glioma cell migration via modulating the phosphorylation of PP2A,which in turn altered the activity of p38 (P<0.01).Conclusion PDCD10 may mediate glioma cell migration by regulating PP2A/p38 signaling.

Key words: programmed cell death 10, glioma, migration, PP2A/P38

[1] JIANG Fan, XIE Keqi. Impacts of butorphanol on the proliferation,apoptosis and migration of esophageal cancer cells by regulating CCL2-CCR2 axis [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(2): 168-172.
[2] CHEN Jixin, LIAO Peng, ZHOU Yuhuai, Liu Tianyun. CircHERC4 inhibits the proliferation,migration and invasion of colorectal cancer cells by regulating the miR-105-5p/Skp2 axis [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 733-737.
[3] ZENG Qiang, ZHANG Yu, CHEN Hui, et al. Leucine-rich-alpha2-glycoprotein 1 regulates proliferation,migration and invasion of non-small cell lung cancer cells through RUNX1/OPN signaling [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(6): 562-567.
[4] SHI Panjie, WANG Yongheng, HAN Yingjie, ZHAO Jianhua, HAN Zhiguang, HAN Ying. Prognosis of epilepsy after operation for low-grade insular glioma [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(11): 1023-1026.
[5] LAO Yaojia, CHENG Jie, LIN Menglu, ZHANG Haiping, FENG Jiahui, MOU Juanli, HUANG Kai, HU Fan, LIN Jun. Effect of LIM kinase 1 on the proliferation,migration and ability to promote angiogenesis of hepatocellular carcinoma cells [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(10): 920-924.
[6] LIU Kai, LI Bo, WU Xiangtian, et al. Mechanism study of metformin inhibiting migration and invasion of non-small cell lung cancer A549 cell through LncRNA-H19 [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 719-721.
[7] LI Xin, GAI Huirong, SONG Lei, et al. SRGAP3-AS2 regulates non-small cell lung cancer cell proliferation,migration and invasion via JAK signaling pathway [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 727-730.
[8] YIN Junfeng, GU Ming. The effect of circ_0007385 silence on the proliferation,migration and apoptosis of colon cancer cells [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 762-766.
[9] ZHENG Yue, LUO Liangsheng. Related mechanism and representative molecules of LncRNA in glioma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 290-293.
[10] ZHOU Luowen, WANG Junwen, SHU Kai, et al. Clinical significance of POU3F2 expression in glioma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 138-141.
[11] CAO Lei, ZHANG Chengli, HOU Ying. The effects of miR-367-3p regulating CCND2 expression on the proliferation and migration of lung cancer cells [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(12): 1123-1127.
[12] ZHANG Yuping, SONG Lei, LI Chunyan, et al. LINC00221 promotes proliferation,migration and invasion in hepatocellular carcinoma through ERK signaling pathway [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(11): 1037-1040.
[13] ZHU Min, DENG Kexue, QIU Jun, et al. Evaluation of glioma grade by IVIM and its correlation with Ki-67 index [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(10): 925-929.
[14] WANG Gang, LEI Chao, WEN Daping. Expression of lncRNA-PCAT6 and miR-16 in human glioma and their relationship with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(10): 948-951.
[15] CHENG Lidong, LIU Jingdian, SHU Kai. Current status and progress of molecular research and targeted therapy for glioma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(10): 998-1000.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 729 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 735 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 737 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 744 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 747 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 760 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 764 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 766 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 769 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
Copyright © JOURNAL OF CLINICAL SURGERY, All Rights Reserved.
Tel: 027-87893476　E-mail: whlcwk@126.com
Powered by Beijing Magtech Co. Ltd